Dr Hofseth is an Associate Professor in the Department of Pharmaceutical and Biomedical Sciences at the South Carolina College of Pharmacy University of South Carolina.  Overall his research interests revolve around chronic inflammation and cancer  Chronic inflammation is dangerous to human health It drives many prevalent diseases in our society including heart disease diabetes Alzheimerrsquo;s and cancer, Current treatment strategies to dampen signs and symptoms of chronic inflammation are limited and fraught with sideeffects Dr. Hofseth has dedicated his career to identifying novel targets and therapeutic approaches to suppressing inflammation with minimal toxicity. One way is through the use of common complementary and alternative medicines that have antiinflammatory properties. Another way is to team up with biochemists who synthesize small molecule inhibitors of specific proinflammatory molecules. Dr. Hofseth also carryies out clinical trials to examine the role of antioxidants in suppressing systemic inflammation and improve overall health Our benchtobedside approach will have farreaching health implications on millions of people suffering from autoimmune and chronic inflammatory diseases. Dr. Hofseth has published over 50 times in peerreviewed journals. Dr Hofseth is an Associate Professor in the Department of Pharmaceutical and Biomedical Sciences at the South Carolina College of Pharmacy University of South Carolina.  Overall his research interests revolve around chronic inflammation and cancer  Chronic inflammation is dangerous to human health It drives many prevalent diseases in our society including heart disease diabetes Alzheimerrsquo;s and cancer, Current treatment strategies to dampen signs and symptoms of chronic inflammation are limited and fraught with sideeffects Dr. Hofseth has dedicated his career to identifying novel targets and therapeutic approaches to suppressing inflammation with minimal toxicity. One way is through the use of common complementary and alternative medicines that have antiinflammatory properties. Another way is to team up with biochemists who synthesize small molecule inhibitors of specific proinflammatory molecules. Dr. Hofseth also carryies out clinical trials to examine the role of antioxidants in suppressing systemic inflammation and improve overall health Our benchtobedside approach will have farreaching health implications on millions of people suffering from autoimmune and chronic inflammatory diseases. Dr. Hofseth has published over 50 times in peerreviewed journals.

Chronic inflammation and cancer,Complementary and Alternative Medicine, Targeting Peptidylarginine Deiminases to suppress colitis and colon cancer, Targeting Sphingosine Kinases to suppress colitis and colon cancer,Inflammatory load and human health